The University of Southampton
University of Southampton Institutional Repository

Moderators of response to stimulants for preschool attention-deficit/hyperactivity disorder

Moderators of response to stimulants for preschool attention-deficit/hyperactivity disorder
Moderators of response to stimulants for preschool attention-deficit/hyperactivity disorder
Objective: this study aimed at identifying moderators of efficacy of stimulants against placebo to inform personalized recommendations for treatment in preschool children (< 6 years) with attention-deficit/hyperactivity disorder (ADHD).

Method: we acquired individual-level participant data from two randomized placebo-controlled trials (RCTs) of preschool ADHD: MAPPA (8-week methylphenidate, 102 participants, Brazil) and SPD489-347 (6-week lisdexamfetamine, 148 participants, US). We evaluated the moderator and predictor effects of baseline demographic (age, sex, race, ethnicity, maternal educational level) and baseline clinical (ADHD symptom severity, intelligence quotient, number of psychiatric comorbidities) characteristics, as available, on endpoint ADHD symptom severity scores. Data from each study were analyzed separately with linear mixed-effects model for repeated measures. For categorical variables, we also computed treatment effects (i.e., stimulants versus placebo) within subgroups and, when possible, pooled them alongside subgroup data from PATS (5-week methylphenidate, 165 participants, US) in random-effects meta-analyses.

Results: stimulants had greater efficacy against placebo in White children compared to Black children considering data from US studies. Older age was not a moderator of greater efficacy of stimulants against placebo, nor was it associated with worse ADHD symptom severity at endpoint. Greater baseline ADHD symptom severity was associated with higher ADHD symptom severity at endpoint independently of the assigned treatment group.

Conclusion: race, but not older age or baseline ADHD symptom severity, may moderate the efficacy of stimulants for preschool ADHD. Given the post hoc nature of subgroup analyses, the findings should be interpreted as exploratory and viewed as hypothesis for confirmation in future studies.
Randomized Controlled Trial; Amphetamine; Methylphenidate
1527-5418
Farhat, Luis C.
c4eb65e6-7fd3-43ed-891e-3584e83ce20b
Sugaya, Luisa Shiguemi
3df2795e-e3f7-493f-8555-fbe9061a73ff
Bloch, Michael H.
b0629a2d-eef2-4dc4-894f-c1d1779db227
Childress, Ann
0b4b72c0-c670-467b-9cb4-c94f4fb5b923
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Fatori, Daniel
a126e159-95ac-4821-9a83-06a702db00dc
Salum, Giovanni A.
0f583594-247d-4b0d-b646-0bdac597c60d
Rohde, Luis Augusto
0cf3b1d3-7d83-4dc9-9cec-6d79276ead66
Polanczyk, Guilherme V.
794ddae7-f894-48fc-a90a-af190ab728a8
Farhat, Luis C.
c4eb65e6-7fd3-43ed-891e-3584e83ce20b
Sugaya, Luisa Shiguemi
3df2795e-e3f7-493f-8555-fbe9061a73ff
Bloch, Michael H.
b0629a2d-eef2-4dc4-894f-c1d1779db227
Childress, Ann
0b4b72c0-c670-467b-9cb4-c94f4fb5b923
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Fatori, Daniel
a126e159-95ac-4821-9a83-06a702db00dc
Salum, Giovanni A.
0f583594-247d-4b0d-b646-0bdac597c60d
Rohde, Luis Augusto
0cf3b1d3-7d83-4dc9-9cec-6d79276ead66
Polanczyk, Guilherme V.
794ddae7-f894-48fc-a90a-af190ab728a8

Farhat, Luis C., Sugaya, Luisa Shiguemi, Bloch, Michael H., Childress, Ann, Cortese, Samuele, Fatori, Daniel, Salum, Giovanni A., Rohde, Luis Augusto and Polanczyk, Guilherme V. (2025) Moderators of response to stimulants for preschool attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry. (doi:10.1016/j.jaac.2025.09.012).

Record type: Article

Abstract

Objective: this study aimed at identifying moderators of efficacy of stimulants against placebo to inform personalized recommendations for treatment in preschool children (< 6 years) with attention-deficit/hyperactivity disorder (ADHD).

Method: we acquired individual-level participant data from two randomized placebo-controlled trials (RCTs) of preschool ADHD: MAPPA (8-week methylphenidate, 102 participants, Brazil) and SPD489-347 (6-week lisdexamfetamine, 148 participants, US). We evaluated the moderator and predictor effects of baseline demographic (age, sex, race, ethnicity, maternal educational level) and baseline clinical (ADHD symptom severity, intelligence quotient, number of psychiatric comorbidities) characteristics, as available, on endpoint ADHD symptom severity scores. Data from each study were analyzed separately with linear mixed-effects model for repeated measures. For categorical variables, we also computed treatment effects (i.e., stimulants versus placebo) within subgroups and, when possible, pooled them alongside subgroup data from PATS (5-week methylphenidate, 165 participants, US) in random-effects meta-analyses.

Results: stimulants had greater efficacy against placebo in White children compared to Black children considering data from US studies. Older age was not a moderator of greater efficacy of stimulants against placebo, nor was it associated with worse ADHD symptom severity at endpoint. Greater baseline ADHD symptom severity was associated with higher ADHD symptom severity at endpoint independently of the assigned treatment group.

Conclusion: race, but not older age or baseline ADHD symptom severity, may moderate the efficacy of stimulants for preschool ADHD. Given the post hoc nature of subgroup analyses, the findings should be interpreted as exploratory and viewed as hypothesis for confirmation in future studies.

Text
2025_08_20_TitlePage_IPDModeratorsADHD - Accepted Manuscript
Restricted to Repository staff only until 18 September 2026.
Request a copy
Text
2025_08_20_Manuscript_IPDModeratorsADHD clean - Accepted Manuscript
Restricted to Repository staff only until 18 September 2026.
Request a copy
Text
Figure - Accepted Manuscript
Restricted to Repository staff only until 18 September 2026.
Request a copy

More information

Accepted/In Press date: 11 September 2025
e-pub ahead of print date: 18 September 2025
Keywords: Randomized Controlled Trial; Amphetamine; Methylphenidate

Identifiers

Local EPrints ID: 506075
URI: http://eprints.soton.ac.uk/id/eprint/506075
ISSN: 1527-5418
PURE UUID: 0675af3a-0500-4629-a018-e445e9f4b6cb
ORCID for Samuele Cortese: ORCID iD orcid.org/0000-0001-5877-8075

Catalogue record

Date deposited: 28 Oct 2025 17:56
Last modified: 29 Oct 2025 02:49

Export record

Altmetrics

Contributors

Author: Luis C. Farhat
Author: Luisa Shiguemi Sugaya
Author: Michael H. Bloch
Author: Ann Childress
Author: Samuele Cortese ORCID iD
Author: Daniel Fatori
Author: Giovanni A. Salum
Author: Luis Augusto Rohde
Author: Guilherme V. Polanczyk

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×